Korea

Novosis Putty Sets the Stage for U.S. Market Success with Promising Clinical Results

SEOUL, South Korea, May 14, 2024 /PRNewswire/ -- CGBio, a leading medical device company, announced a significant clinical results demonstrating a 100% interbody fusion success rate at 52 weeks for its innovative bone substitutes, "Novosis" and "Excelos Inject," which have been published in the '...

2024-05-14 20:00 1724

YoungManDduk Captivates the U.S. with Oranda: The Rise of K-Desserts at Costco

SEOUL, South Korea, May 14, 2024 /PRNewswire/ -- The Korean brand YoungManDduk's Oranda Snack Bars has started selling in Costco stores in the LA area and was greeted with excitement by US consumers. This success serves as an important milestone in showcasing the allure of Korean culture and K-f...

2024-05-14 13:00 1366

SK chemicals Targets the North American market with Circular Recycling Technology participating in NPE 2024

* Exhibition of circular recycled materials and waste plastic recycling comprehensive solutions * "We will further accelerate our expansion into North America by strengthening brand owner marketing." ORLANDO, Fla. and SEONGNAM, South Korea, May 13, 2024 /PRNewswire/ -- Following Chinaplas las...

2024-05-13 21:00 2439

LG Display's Research Results on OLEDoS for VR Selected as Distinguished Paper at SID Display Week 2024

SEOUL, South Korea, May 13, 2024 /PRNewswire/ -- LG Display, the world's leading innovator of display technologies, announced today that its research paper on OLEDoS for virtual reality (VR) has been selected as a Distinguished Paper of the Year by the Society for Information Display (SID), the w...

2024-05-13 21:00 2152

MetisX, a fabless startup in South Korea, raises $44M in Series A funding

SEOUL, South Korea, May 13, 2024 /PRNewswire/ -- MetisX, a fabless startup based inSouth Korea, has recently secured $44 million in Series A funding, bringing its total funding to over$50 million. The company, established in 2022, focuses on developing intelligent memory solutions using Compute E...

2024-05-13 20:00 1973

Nuvilab Becomes B Corp Certified

SEOUL, South Korea, May 10, 2024 /PRNewswire/ -- Nuvilab, a leading provider of food vision AI, announced its recent achievement of becoming a certified B Corp. The designation, granted by the non-profit B Lab, highlights Nuvilab's commitment to a range of sustainable practices encompassing gover...

2024-05-10 19:59 2506

SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer

SEOUL, South Korea, May 9, 2024 /PRNewswire/ -- SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (SCLC) for SNB-101 (API: SN-38), a new drug for polymer nanoparticle anticancer under clinical trial. SNB-101 ...

2024-05-10 12:00 1460

SK hynix Develops Next-Generation Mobile NAND Solution ZUFS 4.0

* Mass production of industry's best-performing product for on-device AI smartphones to begin in 3Q * Performance degradation over time improved, while lifetime increased by 40% * SK hynix to expand leadership in AI memory space with strong presence in NAND solutions following success of HBM...

2024-05-09 08:00 1463

Sold out: Registration opens for in-cosmetics Korea 2024

SEOUL, South Korea, May 8, 2024 /PRNewswire/ -- in-cosmetics Korea,  the only exhibition dedicated to personal care ingredients inSouth Korea, has announced that registration is open for the 2024 event, taking place in Hall C at the COEX, Seoul...

2024-05-09 07:00 1263

Preparations for CIIE 2024 in full swing

SHANGHAI, May 8, 2024 /PRNewswire/ -- The seventh China International Import Expo (CIIE), hailed as an access point for global companies looking to expand their presence in the Chinese market, is scheduled to take place this November inShanghai.

2024-05-08 20:30 2514

TiumBio Announces Positive Topline Data from Phase 2a Trial of Merigolix in Patients with Moderate to Severe Endometriosis-Associated Pain

* The study (NCT05138562) met its primary endpoint of change of dysmenorrhea (menstrual pain) score from baseline to 12 weeks compared to placebo across all tested doses (120 mg, 240 mg, and 320 mg)  * Merigolix is expected to emerge as a best-in-class treatment based on its excellent pain re...

2024-05-08 20:00 1237

Hygenco to set up a green hydrogen/ammonia project at Tata Steel SEZ's Gopalpur Industrial Park

BHUBANESWAR, India, May 7, 2024 /PRNewswire/ -- HHP Five Private Limited (subsidiary of Hygenco Green Energies Pvt Ltd) a pioneer in producing low-cost green hydrogen, has formally entered into a binding agreement with Tata Steel Special Economic Zone Industrial Park (GIP), to establish a large-s...

2024-05-07 17:16 1433

GC Genome to Present New Clinical Data on Colorectal Cancer Detection at the ASCO Annual Meeting 2024

YONGIN, South Korea, May 7, 2024 /PRNewswire/ -- GC Genome Corporation, a leading diagnostics company, today announced that it will present the new clinical data of its AI-based liquid biopsy platform on colorectal cancer detection at the 2024 American Society of Clinical Oncology (ASCO) Annual ...

2024-05-07 13:27 1359

Hyundai Motor Company's SUNG WOO SHIN Appointed to STRADVISION Board of Directors

SEOUL, South Korea, May 6, 2024 /PRNewswire/ -- STRADVISION , a leader in the automotive technology sector, proudly welcomesSUNG WOO SHIN from Hyundai Motor Company to its esteemed board of directors.

2024-05-06 23:00 1517

German car manufacturer visits HoneyNaps, a South Korean sleep tech company, to develop new automotive healthcare applications

Monitoring biosignals for both drivers and passengers - Analyzing and diagnosing with FDA-approved algorithm SEOUL, South Korea, May 6, 2024 /PRNewswire/ -- Amid the rapid advancement in automobile healthcare and digital healthcare markets, global car manufacturers are racing to adopt cutting ed...

2024-05-06 22:00 1394

HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled VELOS-4 Trial Evaluating Tanfanercept for Treatment of Dry Eye Disease

* HanAll has initiated a Phase III VELOS-4 study to evaluate the efficacy and safety of tanfanercept in dry eye based on the findings from the previous Phase III VELOS-3 study. * Tanfanercept demonstrated statistically significant improvement on the secondary outcome measure, Schirmer testing...

2024-05-03 19:00 2334

QANDA Named to TIME's Inaugural List of the World's Top EdTech Companies in 2024

LOS ANGELES, May 2, 2024 /PRNewswire/ -- Mathpresso, creator of Asia's leading learning app, QANDA, today announced that it has been recognized byTIME's World's Top EdTech Companies in 2024 . Presented by TIME and Statista Inc., this...

2024-05-03 07:27 2120

Boryung Launches 2024 Humans In Space Challenge: Sending Experiments into Orbit

* Boryung to support the launch of space experiments into orbit for selected startups and researchers * Held for the third consecutive year, HIS presents an expanded ecosystem of engagements with NASA, ISS National Lab,MIT, and major space companies * Humans In Space(HIS) will serve as a glo...

2024-05-02 20:00 1658

Hanwha Launches Engine Leasing Platform

* South Korea's 7th largest business enterprise has launched 'Hanwha Aviation', an engine leasing and trading platform with a long-term vertically integrated strategy for newer generation assets. * Hanwha will apply extensive experience and expertise in aero engines, finance, and asset manage...

2024-05-02 17:30 1399

Korea Electric Power Corporation Files 2023 Annual Report on Form 20-F

NAJU, South Korea, April 30, 2024 /PRNewswire/ -- On April 30, 2024, Korea Electric Power Corporation (NYSE: KEP) ("KEPCO") filed its annual report including audited consolidated financial statements on Form 20-F for the year endedDecember 31, 2023 with the U.S. Securities and Exchange Commission...

2024-05-01 04:22 3143
1 ... 13141516171819 ... 110